Helen M. Burt
Dr. Burt was born in Manchester, England and obtained her BPharm (honours) from the University of Bath and her PhD in pharmaceutics from UBC. She is the Angiotech professor of drug delivery in the UBC Faculty of Pharmaceutical Sciences, and began her term as associate vice-president, research & international in 2011.
Dr. Burt's major research efforts are supported by grants from CIHR and NSERC and involve the development of polymer-based drug delivery systems for controlled and localized drug delivery. She has published over 140 peer-reviewed papers and holds eight patents. She is a founding scientist in the Centre for Drug Research and Development (CDRD), a member of the Canadian Academy of Health Sciences, and has served on the board of directors of the Provincial Health Services Authority.
Dr. Burt's projects primarily focus on nanotechnology as applied to the development of innovative nano-sized drug carriers. These carriers, known as nanoparticulate drug delivery systems, are designed to deliver their drug payload to different sites in the body and release the drug at controlled rates. Nanoparticulate drug delivery systems are an exciting new technology with potential applications in a broad range of disease states, including cancer, arthritis, tissue regeneration, infectious diseases and many more.